GS MZ1 12.5 (Promacta 12.5 mg)
Generic Name: eltrombopag
Pill with imprint GS MZ1 12.5 is White, Round and has been identified as Promacta 12.5 mg. It is supplied by GlaxoSmithKline.
Promacta is used in the treatment of aplastic anemia; idiopathic thrombocytopenic purpura; thrombocytopenia; thrombocytopenia idiopathic and belongs to the drug class platelet-stimulating agents. Risk cannot be ruled out during pregnancy. Promacta 12.5 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for GS MZ1 12.5
Promacta
- Generic Name
- eltrombopag
- Imprint
- GS MZ1 12.5
- Strength
- 12.5 mg
- Color
- White
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Platelet-stimulating agents
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- GlaxoSmithKline
- National Drug Code (NDC)
- 00007-4643
More about Promacta (eltrombopag)
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Compare Alternatives
- Pricing & Coupons
- En Español
- 6 Reviews
- Drug class: platelet-stimulating agents
- FDA Alerts (2)
- FDA Approval History
Consumer resources
- Promacta
- Promacta (Eltrombopag Powder for Suspension)
- Promacta (Eltrombopag Tablets)
- Promacta (Advanced Reading)
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
